Dr. Jeff Boyle, CSO of Addimmune™, brings over 25 years of expertise in immunology research, assay development, and commercialization. He has held leadership roles in biopharmaceutical and diagnostic companies, including serving as President of Ellume USA LLC, where he established a state-of-the-art manufacturing facility for COVID-19 home tests. Jeff has a strong track record, including executive roles at QIAGEN and R&D leadership positions at CSL Ltd. He boasts a prolific research career with 30 publications and a portfolio of patents in vaccines, immuno-oncology, and medical devices. Jeff is skilled in managing IP assets, strategic initiatives, and product development related to diagnostics, immune stimulation, and oncology therapies.